FREE PSA AND CLINICALLY SIGNIFICANT ANDFATAL PROSTATE CANCER IN THE PLCO SCREENING TRIAL

被引：0
|
作者：
Yim, Kendrick
Ma, Chaoran
Carlsson, Sigrid
Lilja, Hans
D'Andrea, Vincent
Mucci, Lorelei
Penney, Kathryn
Preston, Mark
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD38-09
引用
收藏
页码：E996 / E997
页数：2
相关论文
共 50 条
  • [41] PSA based screening has significant impact on prostate cancer volume
    Steiner, H
    Berger, A
    Spranger, R
    Hager, M
    Moser, P
    Horninger, W
    Bartsch, G
    JOURNAL OF UROLOGY, 2003, 169 (04): : 427 - 427
  • [42] Identification of clinically significant prostate cancer by prostate-specific antigen screening
    Smith, RP
    Malkowicz, SB
    Whittington, R
    VanArsdalen, K
    Tochner, Z
    Wein, A
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (11) : 1227 - 1230
  • [43] PRE-BIOPSY PROSTATE CANCER NOMOGRAMS BASED UPON SERIAL PSA SCREENING DATA IN THE PLCO TRIAL WITH VERIFICATION BIAS CORRECTION
    Izmirlian, Grant
    Grubb, Robert L., III
    Black, Amanda
    Prorok, Philip C.
    Berg, Christine D.
    Crawford, E. David
    Andriole, Gerald L., Jr.
    Kibel, Adam S.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 609 - 609
  • [44] Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    O'Brien, B
    Nichaman, L
    Browne, JEH
    Levin, DL
    Prorok, PC
    Gohagan, JK
    Sullivan, D
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 310S - 328S
  • [45] PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MEN 60 TO 70 YEARS OF AGE PREDICT AGGRESSIVE PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL: IMPLICATIONS FOR RISK-STRATIFIED SCREENING
    Berger, Alexandra
    Aden-Buie, Garrick
    Kibel, Adam
    Mucci, Lorelei
    Penney, Kathryn
    Wilson, Kathryn
    Gerke, Travis
    Preston, Mark
    JOURNAL OF UROLOGY, 2019, 201 (04): : E559 - E559
  • [46] Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial
    Hoyt, Margaret
    Reger, Michael
    Marley, Andrew
    Fan, Hao
    Liu, Ziyue
    Zhang, Jianjun
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (02): : 392 - 401
  • [47] EFFECT OF OBESITY AT AGE 20 AND 50 ON DEVELOPMENT OF PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL
    Grubb, Robert L., III
    Black, Amanda
    Church, Timothy R.
    Hickey, Thomas
    Izmirlian, Grant
    Riley, Thomas
    Prorok, Philip C.
    Berg, Christine D.
    Crawford, E. David
    Andriole, Gerald L., Jr.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 61 - 62
  • [48] Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Maattanen, Liisa
    Huhtala, Heini
    Platz, Elizabeth A.
    Ala-Opas, Martti
    Stenman, Ulf-Hakan
    Auvinen, Anssi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) : 1650 - 1659
  • [49] Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study
    Rannikko, Antti
    Leht, Mare
    Mirtti, Tuomas
    Kenttamies, Anu
    Tolonen, Teemu
    Rinta-Kiikka, Irina
    Kilpelainen, Tuomas P.
    Natunen, Kari
    Lilja, Hans
    Lehtimaki, Terho
    Raitanen, Jani
    Kujala, Paula
    Ronkainen, Johanna
    Matikainen, Mika
    Petas, Anssi
    Taari, Kimmo
    Tammela, Teuvo
    Auvinen, Anssi
    BJU INTERNATIONAL, 2022, 130 (02) : 193 - 199
  • [50] Specificity of prostate cancer screening with PSA:: Finnish ERSPC trial
    Tammela, TL
    Auvinen, A
    Määttänen, L
    Stenman, UH
    Ala-Opas, M
    Ruutu, M
    Juusela, H
    Hakama, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 431 - 431
12345